Industrial manufacturer Standex (NYSE: SXI) met Wall Street’s revenue expectations in Q1 CY2026, with sales up 8.1% year on year to $224.6 million. Its non-GAAP profit of $2.21 per share was in line with analysts’ consensus estimates.

Is now the time to buy SXI? Find out in our full research report (it’s free for active Edge members).

StockStory’s Take

Standex’s first quarter results were met with a negative market reaction, despite revenue and adjusted EPS aligning with Wall Street’s expectations. Management pointed to organic growth in its Electronics and Aerospace & Defense segments, as well as an ongoing shift toward fast-growing end markets. CEO David Dunbar explained that new product sales and continued portfolio simplification, notably the divestiture of Federal Industries, were significant contributors to the quarter’s performance. The company also emphasized that higher-margin, custom-engineered solutions now represent a larger share of its business mix, helping to offset weaker results in Scientific and certain industrial sectors.

Looking forward, Standex’s outlook centers on expanded capacity for its grid and aerospace businesses, continued investment in new product development, and targeted acquisitions in engineered components. Management expects momentum in fast-growth markets such as space, defense, and the electrical grid to support higher sales, with more than 15 product launches planned this year. However, CEO David Dunbar acknowledged that near-term margin expansion may be tempered by growth investments and higher variable compensation, stating, “We expect slightly lower adjusted operating margin as organic growth and realization of productivity actions are more than offset by growth investments in capacity expansions, higher medical costs and increased variable compensation expenses.”

Key Insights from Management’s Remarks

Management attributed the quarter’s results to strong performance in Electronics and Aerospace & Defense, effective portfolio simplification, and robust new product sales, while noting some margin impact from ongoing investments and divestitures.

• Electronics and Aerospace & Defense momentum: Standex’s Electronics segment saw robust organic growth, driven by increased demand for grid and relay products, while Aerospace & Defense benefited from higher project activity, particularly in space and missile nose cone solutions. Both segments are now the main profit engines, representing about 70% of sales and nearly 80% of total segment profits.

• Portfolio simplification accelerates: The completed divestiture of Federal Industries allowed Standex to focus capital and management resources on higher-growth, higher-margin businesses. This move reduced the company’s business count from 16 to 5 over the last decade, streamlining its operations and improving its growth profile.

• New product launches underpin growth: New product sales grew approximately 40% year-on-year, driven by ongoing innovation in Electronics and Aerospace & Defense. The company expects new products to add roughly 300 basis points of organic growth for 2026, and more than 15 additional product launches are planned this year.

• Capacity expansion in grid and global footprint: Standex invested in expanding production capacity across its Texas, India, and new Croatia sites to meet strong demand in grid-related end markets. The Croatia facility, recently operational, is expected to accelerate shipments once certifications are complete, opening access to the larger European market.

• Margin dynamics and growth investments: Adjusted operating margins improved overall, but management noted that growth investments—particularly in new facilities and product launches—temporarily weighed on segment margins. The impact of these investments is expected to moderate as new capacity comes online and volume ramps up.

Drivers of Future Performance

Standex’s outlook for the coming year is shaped by growth in fast-growing end markets, increased new product introductions, and continued capacity expansion, balanced by near-term margin pressure from ongoing investments.

• Expansion in fast-growth markets: Management expects continued strength from space, defense, and grid sectors, with sales into these end markets projected to constitute about 30% of total revenue. The company’s repositioning around these segments aims to deliver mid- to high-single digit organic growth and support long-term sales momentum.

• Ongoing new product development: The launch of more than 15 new products this year, following 16 launches last year, is expected to add nearly 300 basis points of organic growth. Management believes this pipeline will drive incremental revenue and deepen customer relationships, particularly in custom-engineered solutions.

• Margin headwinds from investments: While Standex anticipates slightly higher revenue in the next quarter, adjusted operating margin is expected to be slightly lower year-over-year. Growth investments in capacity expansions, higher medical costs, and increased variable compensation are expected to offset productivity gains, potentially limiting near-term margin expansion.

Catalysts in Upcoming Quarters

Looking ahead, our analysts will be watching (1) execution on new product launches and their contribution to organic growth; (2) the pace of capacity ramp-up at the Croatia, India, and Texas facilities; and (3) the scale and timing of new defense and grid orders, particularly as government procurement decisions and European market penetration unfold. Ongoing portfolio adjustments and any updates on additional divestitures will also serve as key markers of progress.

Standex currently trades at $248.63, down from $273 just before the earnings. At this price, is it a buy or sell? The answer lies in our full research report (it’s free).

High Quality Stocks for All Market Conditions

ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.

Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.